α2-Adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice
- 17 April 2000
- journal article
- Published by Elsevier in Brain Research
- Vol. 862 (1-2) , 26-35
- https://doi.org/10.1016/s0006-8993(00)02089-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Sympathoinhibitory Function of the α 2A -Adrenergic Receptor SubtypeHypertension, 1999
- Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild‐type and D79N α2A‐adrenoceptor transgenic miceBritish Journal of Pharmacology, 1999
- Activation of phosphatidylcholine-selective phospholipase C by I1-imidazoline receptors in PC12 cells and rostral ventrolateral medullaBrain Research, 1997
- Central Hypotensive Effects of the α 2a -Adrenergic Receptor SubtypeScience, 1996
- Central neural organization and control of sympathetic nervous system in mammalsProgress in Neurobiology, 1995
- Optimization of Radioligand Binding Assays for I1‐Imidazoline Sitesfn1Annals of the New York Academy of Sciences, 1995
- Selective Antihypertensive Action of Moxonidine Is Mediated Mainly by I1-Imidazoline Receptors in the Rostral Ventrolateral MedullaJournal of Cardiovascular Pharmacology, 1994
- Distributions of mRNAs for alpha‐2 adrenergic receptor subtypes in rat brain: An in situ hybridization studyJournal of Comparative Neurology, 1993
- Demonstration of high- and low-affinity β-adrenergic receptors in slide-mounted sections of rat and human brainBrain Research, 1990
- Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agentsBrain Research Reviews, 1984